Table 2.

Clinical outcomes of patients who had undergone transcatheter aortic valve replacement according to the presence or absence of COVID-19.

	Entire Cohort (n = 702)	COVID-19 (n = 22)	No COVID-19 (n = 680)	p Value
Hospitalization–n (%)	25 (3.6)	13 (59.1)	12 (1.8)	<0.0001
Conventional unit	22 (3.2)	10 (45.5)	12 (1.8)	<0.0001
Intensive care unit	3 (0.44)	3 (13.6)	0 (0)	<0.0001
Mortality from January 1, 2020–n (%)
All-cause mortality	48 (6.8)	10 (45.5)	38 (5.6)	<0.0001
Cardiovascular mortality	20 (2.8)	0 (0)	20 (2.8)	0.414
COVID-19 mortality	10 (1.5)	10 (45.5)	0 (0)	<0.0001
COVID-19 severity–n (%)
COVID-19 related hospitalization or death	14 (2.0)	14 (63.6)	0 (0)	<0.0001

Abbreviations: COVID-19: Coronavirus Disease 2019.